Bank of America’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bank of America’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-117,400	Closed	-$709K	–	7372
2019 Q4	$709K	Buy	+117,400	New	+$803K	﹤0.01%	4760

Bank of America's ZYNE Position: Q4 2023 in Review

Bank of America sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 282 shares — an estimated $360 sold.

Bank of America first reported a position in ZYNE in Q4 2015 and held it in 29 quarters. The position peaked at $1.31M in Q4 2019. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Bank of America reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Bank of America sold 282 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $360.
Bank of America first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2015 and held it in 29 quarters.
Bank of America's Zynerba Pharmaceuticals, Inc position peaked at $1.31M in Q4 2019.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.